Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma

Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma

Jiaran Zhang,1,* Huichun Tian,1,* Lili Mao,1 Caili Li,1 Xiaoting Wei,1 Junjie Gu,1 Xuan Wang,1 Li Zhou,2 Bin Lian,1 Bixia Tang,1 Xieqiao Yan,2 Siming Li,2 Chuanliang Cui,1 Zhihong Chi,1 Xinan Sheng,2 Jun Guo,1 Lu Si1 1Department of Melanoma and Sarcoma, Peking University Canc...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang J, Tian H, Mao L, Li C, Wei X, Gu J, Wang X, Zhou L, Lian B, Tang B, Yan X, Li S, Cui C, Chi Z, Sheng X, Guo J, Si L
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Cancer Management and Research
Subjects:
Acral melanoma
PD-1
Anti-angiogenesis
Apatinib
Camrelizumab
Temozolomide
Online Access:https://www.dovepress.com/real-world-efficacy-and-safety-of-anti-pd-1-antibody-plus-apatinib-and-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/real-world-efficacy-and-safety-of-anti-pd-1-antibody-plus-apatinib-and-peer-reviewed-fulltext-article-CMAR

Similar Items